Your browser doesn't support javascript.
loading
Automated Blood Sampling in a Canine Telemetry Cardiovascular Model.
Wilsey, Amanda S; Koshman, Yevgeniya E; Weisbecker, Debra A; Bird, Brandan M; Mirakhur, Kuldip K; Sadilek, Sabine; Ebert, Paige A; Polakowski, James S; Foley, C Michael; Medina, Chris L; Mittelstadt, Scott W.
Afiliación
  • Wilsey AS; Department of Safety Pharmacology, Abbvie, North Chicago, Illinois;, Email: amanda.wilsey@abbvie.com.
  • Koshman YE; Department of Safety Pharmacology, Abbvie, North Chicago, Illinois.
  • Weisbecker DA; Department of Comparative Medicine, Abbvie, North Chicago, Illinois.
  • Bird BM; Department of Safety Pharmacology, Abbvie, North Chicago, Illinois.
  • Mirakhur KK; Department of Comparative Medicine, Abbvie, North Chicago, Illinois.
  • Sadilek S; Department of Safety Pharmacology, Abbvie, North Chicago, Illinois.
  • Ebert PA; Department of Comparative Medicine, Abbvie, North Chicago, Illinois.
  • Polakowski JS; Department of Safety Pharmacology, Abbvie, North Chicago, Illinois.
  • Foley CM; Department of Safety Pharmacology, Abbvie, North Chicago, Illinois.
  • Medina CL; Department of Comparative Medicine, Abbvie, North Chicago, Illinois.
  • Mittelstadt SW; Department of Safety Pharmacology, Abbvie, North Chicago, Illinois.
Comp Med ; 71(2): 133-140, 2021 04 01.
Article en En | MEDLINE | ID: mdl-33814031
Successful implementation of automated blood sampling (ABS) into a telemetry instrumented canine cardiovascular model provides simultaneous cardiovascular assessment of novel compounds while collecting multiple blood samples for analysis of drug level, cytokines, and biomarkers. Purpose-bred male Beagle dogs (n = 36) were instrumented with a dual-pressure telemetry transmitter and vascular access port. Modifications to acclimation practices, surgical procedures, and housing were required for implementation of ABS in our established cardiovascular canine telemetry colony. These modifications have increased the use and reproducibility of the model by combining early pharmacokinetic and cardiovascular studies, thus achieving both refinement and reduction from a 3R perspective. In addition, the modified model can shorten timelines and reduce the compound requirement in early stages of drug development. This telemetry-ABS model provides an efficient means to quickly identify potential effects on key cardiovascular parameters in a large animal species and to obtain a more complete pharmacokinetic-pharmacodynamic profile for discovery compounds.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Telemetría / Modelos Cardiovasculares Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Comp Med Asunto de la revista: MEDICINA / MEDICINA VETERINARIA Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Telemetría / Modelos Cardiovasculares Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Comp Med Asunto de la revista: MEDICINA / MEDICINA VETERINARIA Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos